HiFiBiO Therapeutics Logo

Associate Director/Director of Business Development

Cambridge, MassachusettsFull-time
About the Job
Associate Director/Director Business Development.

About HIFIBIO Therapeutics:
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer, autoimmune disorders, and infectious diseases. In addition, HiFiBiO Therapeutics has multiple open-innovation partnerships with industry and academia with the vision to benefit a broad range of cancer patients. For more information, see our website at http://hifibio.com/.

SUMMARY: The Associate Director/Director of Business Development identifies, evaluates, and executes global strategic transactions to build the future of HiFiBiO Therapeutics business development goals and objectives. The position reports to the Chief Operating Officer and will require this individual to have strong interpersonal skills and the ability to interact with all levels of the company, including most senior levels in the organization. The role requires this individual to prioritize, multitask and meet deadlines within short timeframes with an acute eye for details.

RESPONSIBILITIES:
  • Lead search and evaluate therapeutic drug programs through pre-clinical stages of all aspects of drug development and commercialization, mode of actions, preclinical evaluations, regulatory strategy, clinical development path, intellectual property, and commercial potential.
  • Lead search and evaluation to identify strategic partners for the DIS™ platform.
  • Assist in the development of HiFiBiO’s long-term strategic analysis of therapeutic areas beyond HiFiBiO’s current focus proactively.
  • Support the development of a company strategy for maximum value creation and the development/refinement of a business development strategy that aligns with the company strategy.
  • Support the identification, evaluation, and execution of acquisition, investment, and partnership opportunities across a range of therapeutic areas and assets, including Out-licensing/in-licensing opportunities, M&A opportunities, and Research collaborations.
  • Execute complex analytics to assess opportunities (e.g. comparable deal analysis and financial modeling/NPV analysis) and provide diligence support for all transactions (e.g., preparing and setting up diligence files, financing documents, etc.). 
  • Support the drafting and negotiating of transaction term sheets utilizing creative deal structures and processes that result in business success and maximum value.
  • Partner closely with internal and external legal teams to negotiate and implement appropriate legal agreements to support research, development, and commercial goals. 
  • Support program and alliance management, finance, and legal teams in transaction implementation and management.
  • Assessing the landscape for potential partners who are strategically aligned with HIFIBIO’s platform and assets.

QUALIFICATIONS 
  • BS/BA required, Ph.D. or MBA with at least 5-10 years of experience working in a biotech/pharmaceutical company in business development with a track record of executing deals.
  • An understanding of drug discovery and development process.
  • Results-driven.
  • Strong organizational skills, attention to detail, ability to prioritize and meet deadlines across multiple transactions.
  • Ability to explain complex strategic initiatives and advanced scientific/medical challenges across a broad audience.
  • Strong communication and presentation skills across all levels of the organization.
  • Willingness to travel as per business need.
About HiFiBiO Therapeutics

HiFiBiO Therapeutics is an emerging multinational company mobilizing the human immune system to combat disease and transform patient care. We integrate deep-rooted biological expertise, apply advanced single-cell profiling technologies and leverage open-innovation strategies to accelerate the development of a repertoire of innovative antibody drugs to treat cancer and autoimmune disorders.